Home2LB • FRA
add
Iovance Biotherapeutics Inc
Previous close
€1.58
Day range
€1.50 - €1.50
Year range
€1.50 - €11.60
Market cap
586.01M USD
Avg Volume
1.43K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Defense World
1 day ago
Iovance Biotherapeutics (NASDAQ:IOVA) Shares Down 5.4% After Analyst Downgrade
3.23%
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 49.32M | 6,798.46% |
Operating expense | 120.80M | 8.66% |
Net income | -116.16M | -2.82% |
Net profit margin | -235.51 | 98.51% |
Earnings per share | -0.36 | 14.29% |
EBITDA | -113.03M | -2.65% |
Effective tax rate | 1.56% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 359.71M | 0.99% |
Total assets | 966.74M | 11.14% |
Total liabilities | 198.88M | 4.78% |
Total equity | 767.86M | — |
Shares outstanding | 333.93M | — |
Price to book | 0.69 | — |
Return on assets | -32.29% | — |
Return on capital | -38.11% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -116.16M | -2.82% |
Cash from operations | -103.69M | 15.20% |
Cash from investing | 15.87M | 114.23% |
Cash from financing | 143.32M | -25.96% |
Net change in cash | 56.00M | 237.58% |
Free cash flow | -63.94M | 22.41% |
About
Iovance Biotherapeutics, Inc. is a biopharmaceutical startup based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte therapies against cancer. Wikipedia
Founded
2007
Headquarters
Website
Employees
838
